Pyxis Oncology

PYXS· Manufacturing· Fiscal year ends in December

No proxy on file names the CEO of Pyxis Oncology.

Executives3

1Lara Sullivan, M.D.Former President, Chief Executive Officer and Chief Medical OfficerFY2025
2Pamela ConnealyFormer Chief Financial Officer and Chief Operating OfficerFY2025
3Jitendra WadhanePrincipal Financial and Accounting OfficerFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pyxis Oncology paid its 3 named executives $3.9M in total in FY2025 (Dec).

Name
Lara Sullivan, M.D.Former President, Chief Executive Officer and Chief Medical Officer
Pamela ConnealyFormer Chief Financial Officer and Chief Operating Officer
Jitendra WadhanePrincipal Financial and Accounting Officer	Not disclosed	Not disclosed

of each named executive, from the Summary Compensation Table of each proxy.

No disclosed peer group

No proxy on file names a pay peer group for Pyxis Oncology. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Freda Lewis-Hall, M.D.Director · 4 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
Rachel Humphrey, M.D.Director · 3 yr on the boardIndependentCompensation, Nominating and Corporate Governance, Research and Development (Chair)—Paid as an executive
Jakob Dupont, M.D.Director · 2 yr on the boardNot independentResearch and Development—Paid as an executive
Michael A. MetzgerDirector · 1 yr on the boardIndependentAudit, Compensation—Paid as an executive

The board of the latest proxy (FY2025).